Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$8,740,967
+$1,823,263 QoQ
Shares Held
34,736
+9.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#991
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON INVESTMENT MANAGEMENT, INC. holds $48,347,417 across 11 Drug Manufacturers - General names. ABBV ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
48,713 | $12,371,640 | |
| 2 | PFE |
Pfizer Inc
|
469,287 | $11,300,430 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
34,736 | $8,740,967 | |
| 4 | AMGN |
Amgen Inc
|
18,002 | $6,518,884 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,721 | $6,091,644 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,470 | $3,144,395 | |
| 7 | GSK |
GSK plc
|
1,680 | $88,065 | |
| 8 | AZN |
Astrazeneca PLC
|
324 | $61,436 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,740,967 | 34,736 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $6,917,704 | 31,807 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $7,244,960 | 31,708 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $7,405,575 | 31,984 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $6,081,839 | 32,765 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $6,944,121 | 33,143 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $6,842,338 | 38,505 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $7,704,287 | 39,013 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $6,659,435 | 38,826 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $7,091,156 | 38,941 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $6,091,560 | 39,308 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $5,918,427 | 39,705 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $5,427,732 | 40,286 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $6,088,252 | 38,202 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,398,947 | 39,595 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $5,513,481 | 41,081 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $6,629,377 | 43,284 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,691,146 | 47,444 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $7,008,168 | 51,759 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,248,154 | 57,923 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $6,414,397 | 56,946 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,219,619 | 57,472 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $6,075,083 | 56,697 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $4,866,412 | 55,559 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $5,721,635 | 58,277 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,588,161 | 60,220 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||